These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4765794)

  • 1. [Side effects of rifampicin used intermittently in treatment of chronic pulmonary tuberculosis].
    Zierski M; Kucharska A; Wislawska-Orlowska B
    Gruzlica; 1973 Nov; 41(11):1139-45. PubMed ID: 4765794
    [No Abstract]   [Full Text] [Related]  

  • 2. [Side effects of rifampicin in the treatment of chronic pulmonary tuberculosis by the intermittent method].
    Kost A
    Pol Tyg Lek; 1975 Mar; 30(13):557-8. PubMed ID: 1121469
    [No Abstract]   [Full Text] [Related]  

  • 3. [Liver and kidney damage in rifampicin and ethambutol treatment].
    Kozma D; Mihalik P
    Z Erkr Atmungsorgane; 1984; 162(3):249-55. PubMed ID: 6485386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disturbance of liver function caused by postoperative administration of rifampicin and-or ethionamide from standpoint of surgical treatment for pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):201-6. PubMed ID: 4431109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Early results of treatment of patients with chronic pulmonary tuberculosis with rifampicin].
    Böszörmenyi M
    Gruzlica; 1974 May; 42(5):407-10. PubMed ID: 4464228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute renal failure during treatment with Rifampicin].
    Wislawska-Orlowska B; Kucharska A; Graczyk J
    Pol Tyg Lek; 1973 Sep; 28(37):1420-2. PubMed ID: 4759231
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the incidence of Australia antigen in a controlled experiment of treatment with rifampicin].
    Patricolo MR
    Arch Monaldi; 1974; 29(5-6):477-82. PubMed ID: 4467825
    [No Abstract]   [Full Text] [Related]  

  • 9. Rifampicin in the treatment of resistant pulmonary tuberculosis.
    Wäre M; Lorenzen J
    Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 1. A preliminary study. The results of Rifampicin treatment for advanced pulmonary tuberculosis resistant to conventional antituberculous drugs].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):251-6. PubMed ID: 5460317
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampicin in the treatment of chronic pulmonary tuberculosis. Investigations on clinical activity and side effects.
    Pickroth G; Anschel R; Kalich R; Kandt D
    Acta Tuberc Pneumol Belg; 1969; 60(3):513-8. PubMed ID: 5371676
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early results of chronic pulmonary tubersulosis treated with rifomycin].
    Pszonicka A; Lachowicz E; Kozakow H; Styszewska H; Janowiec M; Grabowska R
    Gruzlica; 1971 Jul; 39(7):662-7. PubMed ID: 5117145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatic tolerance in man of rifampicin-isoniazid association].
    Toulet J; Plomteux G; Viteau JM; Abiven M; Bonfante N
    J Med Liban; 1971; 24(6):651-8. PubMed ID: 5146848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin in the treatment of chronic pulmonary tuberculosis. Preliminary report].
    Pacheco CR; Cordero O; López-Malagón S; Sierra D; De Jesús Pacheco M; Vázquez E
    Gac Med Mex; 1973 Jun; 105(6):541-7. PubMed ID: 4731993
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic destructive pulmonary tuberculosis with rifampicin and ethambutol].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5146090
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rifampicin and ethambutol in the treatment of chronic destructive tuberculosis].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5162993
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis.
    Virchow C; Flemming J
    Acta Tuberc Pneumol Belg; 1969; 60(3):466-70. PubMed ID: 5371671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.